Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.

Mr. Kaminskiy is a Сo-Founder and managing partner of Deep Knowledge Group – a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.

He leads the activities of the consortium’s venture arms – Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.

Mr. Kaminskiy is a frequent speaker on the topics of AI and Longevity at conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference” in Silicon Valley, as well as several others at Oxford and Cambridge Universities.

Mr. Kaminskiy is also Co-Founder of Aging Analytics Agency, Deep Knowledge Group’s dedicated Longevity-focused analytical subsidiary, which currently serves as an official member organisation of the United Nations NGO Committee on Ageing and regularly submits policy and strategy proposals to the World Health Organization, World Economic Forum, the UK House of Lords and other national and international policy organizations.

He also supervises the activities of Deep Knowledge group’s 10+ other analytical subsidiaries, including Deep Knowledge AnalyticsDeep Pharma IntelligenceNeuroTech AnalyticsFemTech AnalyticsSpaceTech AnalyticsInvestTech Advanced SolutionsLongevity Financial AdvisorsDeep Knowledge Analytics GovTech / E-Governance DivisionDeep Knowledge Analytics COVID-19 Analytics Division, and Innovation Eye (a joint venture between Deep Knowledge Analytics and Big Innovation Centre, the Secretariat for the UK All-Party Parliamentary Groups on Artificial Intelligence and Blockchain).

In addition to his business activities, Dmitry is involved in several scientific endeavors. He strongly believes that humans should live longer healthier lives. He has a major interest in Healthy Longevity which is reflected in his business, research and public activities.

Mr. Kaminskiy is also author of the critically acclaimed book, Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, published in 2020, which distilled the complex assembly of deep market intelligence and industry knowledge that Deep Knowledge Group and its Longevity-focused subsidiaries have developed over the past 7 years into a full-scope understanding of the Global Longevity Industry, sufficient to define the industry for the first time and to reliably forecast its future development. His newest book, Biomarkers of Human Longevity: Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking, was published 2021.

Dmitry is also the author of a full-fledged Longevity Book Series, comprising a number of upcoming titles including Longevity Financial Industry: Health as New Wealth, Longevity FinTech, WealthTech, InvestTech, InsurTech, AgeTech and the Coming Rise of Longevity Banks, Investment Banks, Stock Exchanges, ETFs, Indices and Novel Financial Instruments and Derivatives, Longevity Politics: Longevity Technocracy, Modern Approaches to Policy, Governance and National Industrial Strategies, and Longevity as the New Political Priority of the 21st Century, and Practical Longevity: The Complete Guide on How to celebrate Your 123rd Birthday, and culminating in the 2022 release of its formal sequel, Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from Longevity Industry 1.0 to 2.0.

Mr. Kaminskiy adheres to the principal of “Impact Investing” in all his business activities, believing that business should intentionally make a significant impact for social good. He operates according to the maxim that business should be aligned with societal good and humanitarianism, and his activities in both business and the non-profit sector are aimed at the shared goal of advancing exponential and disruptive technologies to accelerate positive paradigm shifts in finance, healthcare and AI.